Systematic review and meta-analysis of oral rehabilitation with implants placed into fibula free flaps in the malignant setting
In brief
Dental implants in fibula flaps survive in 93% of cases
Across 35 studies of 979 patients treated for cancer, estimated implant survival was 92.7% and success was 90.6%. These results support implant-based oral rehabilitation after fibula flap reconstruction, but evidence is sparse for upper-jaw implants and limited on how radiotherapy and implant timing affect outcomes; inconsistent reporting also makes comparisons difficult.
- Journal
- International journal of oral and maxillofacial surgery (Q1)
- Published
- 19 November 2026
- Study design
- Systematic review of cohort studies
- Evidence level
- Level 4, Very Low (CEBM 4)
- Authors
- R Newton, S King, C Butterworth
- PMID
- 43057923
- DOI
- 10.1016/j.ijom.2026.10.012
Why clinicians should know about it
- Picked for Plastic and Reconstructive Surgery (paper of the day, 21 November 2026): Meta-analysis reports dental implant survival after fibula flap reconstruction
Abstract
The aim of this review was to explore the evidence on the survival and success of dental implants placed in fibula free flap reconstructions for oral rehabilitation in the malignant setting and factors that may affect these. A search of the MEDLINE and Cochrane CENTRAL databases was performed to identify studies, complemented by manual searching. Studies involving adult humans, published in English, with ≥10 patients with malignant disease and a fibula flap reconstruction receiving dental implants, were included. The assessment of the identified studies and data extraction were performed independently by two reviewers. Risk of bias of the included studies was assessed using a modified ROBINS-I tool. Implant survival and success were analysed using the DerSimonian-Laird random-effects model. Thirty-five studies (979 patients, 3472 implants) were included. Estimated implant survival was 92.7% (95% confidence interval 90.3-94.5%) and success was 90.6% (95% confidence interval 86.9-93.5%). Data was limited for implants explicitly placed into a neo-maxilla compared to a neo-mandible (16 versus 441 implants). Implants placed into fibula free flaps in a malignant setting demonstrate good survival and success. Data is limited for treatment in the maxilla, the impact of radiotherapy, and the timing of implant placement. Reporting of the time to restoration is variable. There is limited but growing evidence of successful, early oral rehabilitation in fibula-based reconstructions in the malignant setting. More research with standardized reporting is required.
Abstract as published, via PubMed.
For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.